Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 2/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19999997 | 0.64 | RAB9A (0.36) | MAPTALDH1A1LMNAKDM4EMEN1 | |
| SCHEMBL24650725 | 0.62 | MAPT (0.50) | MAPTALDH1A1LMNAKDM4EMEN1 | |
| SCHEMBL4098083 | 0.59 | HTR2B (0.31) | — | |
| SCHEMBL1036164 | 0.59 | MAPT (0.38) | MAPTALDH1A1LMNAKDM4EMEN1 | |
| SCHEMBL31319868 | 0.58 | NOS3 (0.34) | MAPTALDH1A1LMNAKDM4EMEN1 | |
| SCHEMBL35211808 | 0.58 | CES2 (0.33) | MAPTALDH1A1LMNAGAARAB9A | |
| SCHEMBL5727673 | 0.58 | NOS3 (0.34) | MAPTALDH1A1LMNAKDM4EMEN1 | |
| SCHEMBL6898456 | 0.58 | CES2 (0.33) | MAPTALDH1A1LMNAGAARAB9A | |
| SCHEMBL5891203 | 0.57 | TTK (0.36) | LMNA | |
| SCHEMBL24202464 | 0.56 | RAB9A (0.44) | MAPTALDH1A1LMNAKDM4EMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11053205-B2 | Phenazine derivatives as antimicrobial agents | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2021-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11053205-B2 | Phenazine derivatives as antimicrobial agents | ROS1, NOX4, PRDX3 | MAPT 2601/4885ALDH1A1 701/4885LMNA 3302/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.